Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III MelanomaAlexander M.M. Eggermont, Ulrich Keilholz, Dirk Schadendorf et al.|Journal of Clinical Oncology|2012Cited by 281